"While Health Canada cannot confirm when submissions are filed by a manufacturer, the department does post regular updates about submissions that have been accepted for review on the Submissions Under Review list," the regulator responded on Wednesday
Patients taking statins who develop new muscle symptoms while on GLP-1 therapy should contact their prescriber promptly, as this combination may increase the risk of muscle-related adverse effects in some individuals
Semaglutides ability to reduce inflammation underscores its value as a multifaceted therapeutic agent, pivotal in the quest for comprehensive well-being
In general, a majority drugs made for treating diabetes aim at enhancing insulin in your system
And a number of approved weight loss medications were taken off the market when they proved to be dangerous
325,326 CD38 controls neutrophil chemotaxis to bacterial chemoattractants via producing cyclic ADP-ribose